Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

Once again...corporate continues to provide us with black & white updates that minimize speculation:

From Q&A May 27, 2019

Christopher J. Moreau CEO of Algernon Pharmaceuticals

The immediate future is focussed around securing the resources required to conduct a minimum of 2 phase II trials, and then focussing on getting the compounds in the clinic and the trials started. The announcement of “first patient enrolled” is always a key milestone to work towards.

We now know (see powerpoint presentation) "first patient enrolled" will be Fall 2019.

Just facts,

/////AMG